GE HealthCare (GEHC) Tops Q2 EPS by 2c, cuts revenue guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
GE HealthCare (GEHC) PT Raised to $92 at Jefferies
July 31, 2024 3:50 PM EDTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $92.00 (from $87.00) while maintaining a Hold rating.
The analyst comments "GEHC reported 2Q24 sales of $4.84B, +1% organic vs cons $4.88B, and EPS of $1.00 (+9%) vs cons $0.98. Orders increased +3%... More
GE HealthCare (GEHC) beats earnings but cuts full-year revenue outlook amid China headwinds
July 31, 2024 6:43 AM EDTGE HealthCare (NASDAQ: GEHC) delivered better-than-expected second-quarter earnings, but the company has tempered its full-year outlook due to headwinds in the Chinese market, sending its shares more than 8% lower in premarket trading.
While the medical technology giant reported adjusted earnings per share (EPS) of $1.00, surpassing analyst estimates by $0.02, revenue came in at $4.84 billion, slightly below expectations of $4.87 billion.
The company attributed the revenue shortfall to... More
